UPDATE 1-Roche to buy U.S. cancer drugmaker Ignyta for $1.7 bln

Dec 22 (Reuters) - Swiss drugmaker Roche will buy U.S. cancer drugmaker Ignyta Inc for $1.7 billion to broaden its oncology portfolio globally, the companies said on Friday.

by support@endlesssupplies.biz (Endless Supplies .Biz) via Endless Supplies .Biz - News